Sorrento Therapeutics, Inc. Stock price
Equities
SRNEQ
US83587F2020
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 USD | 0.00% | 0.00% | -93.52% |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | -11.11% | ||
1 week | -60.00% | ||
Current month | -70.37% | ||
1 month | -70.04% | ||
3 months | -93.64% | ||
6 months | -91.21% | ||
Current year | -93.52% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.008 | 0.00% | 193 787 |
24-03-27 | 0.008 | -11.11% | 210,550 |
24-03-26 | 0.009 | 0.00% | 153,597 |
24-03-25 | 0.009 | +12.50% | 61,686 |
24-03-22 | 0.008 | 0.00% | 103,819 |
Delayed Quote OTC Markets, March 27, 2024 at 03:57 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-93.52% | 4.35M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.69% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |